RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of DNLI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Denali Therapeutics Inc. stock price after Thursday trading.
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 20, 2024 Loss -3.62% PDF

The Denali Therapeutics Inc. stock price fell by -1.20% on the last day (Thursday, 28th Mar 2024) from $20.77 to $20.52. During the last trading day the stock fluctuated 4.57% from a day low at $20.12 to a day high of $21.04. The price has risen in 6 of the last 10 days and is up by 3.9% over the past 2 weeks. Volume has increased on the last day by 190 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 957 thousand shares were bought and sold for approximately $19.64 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.07% during the next 3 months and, with a 90% probability hold a price between $19.21 and $26.90 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

DNLI Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -12.12%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Denali Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $20.42 and $19.48. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Denali Therapeutics Inc. stock

Denali Therapeutics Inc. finds support from accumulated volume at $20.21 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.92 between high and low, or 4.57%. For the last week, the stock has had daily average volatility of 4.85%.

Our recommended stop-loss: $19.79 (-3.54%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 22 days ago.)

Trading Expectations (DNLI) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Denali Therapeutics Inc. to open at $20.56, and during the day (based on 14 day Average True Range), to move between $19.44 and $21.60, which gives a possible trading interval of +/-$1.08 (+/-5.27%) up or down from last closing price. If Denali Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 10.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $20.77 (1.22%) than the support at $20.21 (1.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Denali Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Denali Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.080 Buy Candidate Upgraded

Predicted Opening Price for Denali Therapeutics Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$20.56 ( 0.195%) $20.52

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for DNLI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 21.48 4.68 %
R2 21.13 2.97 %
R1 20.91 1.91 %
Current price: 20.52
Support S1 20.21 -1.52 %
S2 19.99 -2.58 %
S3 19.64 -4.29 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 23.35 13.79 %
R2 20.86 1.66 %
R1 20.77 1.22 %
Current price 20.52
Support S1 20.21 -1.51%
S2 20.13 -1.90%
S3 17.02 -17.06%

FAQ

What is the symbol for Denali Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Denali Therapeutics Inc. is DNLI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Denali Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Denali Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Denali Therapeutics Inc. Stock?
Denali Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Denali Therapeutics Inc. Stock.

What's the current price of Denali Therapeutics Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Denali Therapeutics Inc. (DNLI) share was $20.52.

What is the 52-week high and low for Denali Therapeutics Inc. Stock?
The 52-week high for Denali Therapeutics Inc. Stock is $33.31 and the 52-week low is $15.45.

What is the market capitalization of Denali Therapeutics Inc. Stock?
As of the 2024-03-28, the market capitalization of Denali Therapeutics Inc. is 2.856B.

When is the next earnings date for Denali Therapeutics Inc.?
The upcoming earnings date for Denali Therapeutics Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About Denali Therapeutics Inc.

Denali Therapeutics. Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for ... DNLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT